Documentos relacionados

1. [Diagnosis and management of pure red cell aplasia].
2. [The efficacy of alemtuzumab for pure red cell aplasia associated with autoimmune polyendocrine syndrome type 1].
3. Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis.
4. [Pure red cell aplasia following the rapid reduction and discontinuation of cyclosporine for mixed chimerism after allogeneic bone marrow transplantation].
5. Roxadustat Improves Erythropoietin Antibody-Mediated Pure Red Cell Aplasia in a Patient with Hemodialysis.
6. A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia.
7. Development of pure red cell aplasia by transmission and persistent infection of parvovirus B19 through a kidney allograft.
8. Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia.
9. Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab.
10. Case report: Dynamic antibody monitoring in a case of anti-recombinant human erythropoietin-mediated pure red cell aplasia with prolonged course after kidney transplantation.